NEUMANN CLARKE 4
4 · BIORA THERAPEUTICS, INC. · Filed May 17, 2022
Insider Transaction Report
Form 4
Neumann Clarke
General Counsel and Secretary
Transactions
- Tax Payment
Common Stock
2022-05-15$0.75/sh−8,305$6,229→ 308,320 total - Award
Common Stock
2022-05-15+239,962→ 548,282 total - Award
Stock Option (Right to Buy)
2022-05-15+387,752→ 387,752 totalExercise: $0.75Exp: 2032-05-15→ Common Stock (387,752 underlying)
Footnotes (3)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 24,014 vested restricted stock units on May 15, 2022.
- [F2]Consists of 239,962 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer.
- [F3]This option represents the right to purchase 387,752 shares of the Issuer's common stock, 8,078 of which vested upon grant, with the remaining shares vesting in equal monthly installments through April 15, 2026, subject to the Reporting Person's continued service to the Issuer.